HE3 ANALYSIS OF AN AFFORDABLE PRICE FOR PERFORMANCE-BASED RISK SHARING SCHEME- OMALIZUMAB ADAPTATION IN KOREA
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)73092-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)73092-3/fulltext
Section Title :
RESEARCH PODIUM ABSTRACTS
Section Order :
1251
First Page :
A509
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73092-3&doi=10.1016/S1098-3015(11)73092-3